000			02346 a2200637 4500
005			20250516074330.0
264		0	_c20120611
008			201206s 0 0 eng d
022			_a1945-7197
024	7		_a10.1210/jc.2011-2753 _2doi
040			_aNLM _beng _cNLM
100	1		_avan der Pas, R
245	0	0	_aThe hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy. _h[electronic resource]
260			_bThe Journal of clinical endocrinology and metabolism _cApr 2012
300			_a1303-10 p. _bdigital
500			_aPublication Type: Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aBlood Coagulation _xdrug effects
650	0	4	_aBlood Coagulation Factors _xanalysis
650	0	4	_aCabergoline
650	0	4	_aDopamine Agonists _xadministration & dosage
650	0	4	_aDrug Monitoring
650	0	4	_aDrug Resistance
650	0	4	_aDrug Therapy, Combination _xadverse effects
650	0	4	_aErgolines _xadministration & dosage
650	0	4	_aFibrinolysis _xdrug effects
650	0	4	_aHumans
650	0	4	_aHydrocortisone _xblood
650	0	4	_aKetoconazole _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPituitary ACTH Hypersecretion _xblood
650	0	4	_aPituitary Hormones, Anterior _xantagonists & inhibitors
650	0	4	_aRemission Induction
650	0	4	_aSomatostatin _xadministration & dosage
650	0	4	_aThrombophilia _xchemically induced
650	0	4	_aYoung Adult
700	1		_ade Bruin, C
700	1		_aLeebeek, F W G
700	1		_ade Maat, M P M
700	1		_aRijken, D C
700	1		_aPereira, A M
700	1		_aRomijn, J A
700	1		_aNetea-Maier, R T
700	1		_aHermus, A R
700	1		_aZelissen, P M J
700	1		_ade Jong, F H
700	1		_avan der Lely, A J
700	1		_ade Herder, W W
700	1		_aLamberts, S W J
700	1		_aHofland, L J
700	1		_aFeelders, R A
773	0		_tThe Journal of clinical endocrinology and metabolism _gvol. 97 _gno. 4 _gp. 1303-10
856	4	0	_uhttps://doi.org/10.1210/jc.2011-2753 _zAvailable from publisher's website
999			_c21492315 _d21492315